Cabozantinib promising for advanced adrenocortical carcinoma

For patients with advanced adrenocortical carcinoma, cabozantinib shows promising efficacy, according to a study published online April 9 in The Lancet Oncology.

​Medical Xpress – latest medical and health news stories